Smart thyroid-regulated drug delivery systems: a review of intelligent biosensor-integrated therapeutics for precision thyroxine replacement - Takeaways - MDSpire

Smart thyroid-regulated drug delivery systems: a review of intelligent biosensor-integrated therapeutics for precision thyroxine replacement

  • By

  • Rahul Ingle

  • Gajanan M. Sonwane

  • July 2, 2026

  • 0 min

Share

  • 1

    Levothyroxine replacement therapy is the standard treatment for post-thyroidectomy hypothyroidism but has significant delivery flaws.

  • 2

    Only about 34% of thyroidectomized patients achieve target euthyroidism at their first post-operative follow-up.

  • 3

    Current levothyroxine tablets deliver fixed doses, failing to adjust for individual physiological changes and absorption variability.

  • 4

    The proposed Intelligent Medicine Bot (IMB) would use biosensors and AI to provide adaptive, closed-loop levothyroxine delivery.

  • 5

    Clinical consequences of imprecise thyroid hormone replacement include cardiac arrhythmias, cognitive fog, and metabolic disruption.

Original Source(s)

Smart thyroid-regulated drug delivery systems: a review of intelligent biosensor-integrated therapeutics for precision thyroxine replacement

  • by Rahul Ingle, Gajanan M. Sonwane

  • July 2, 2026

Related Content

Steroid alterations in Cushing’s disease persist after remission: ACTH-driven steroid changes dissociate from mood-regulatory neurosteroids

Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy

Interleukin−1 receptor antagonist and heat shock protein 90alfa are independently associated with fatigue and general health in euthyroid Hashimoto’s thyroiditis